Mestanolone
Systematic (IUPAC) name | |
---|---|
(5α,17β)-17-hydroxy-17-methylandrostan-3-one | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Legal status | |
Routes of administration | Oral |
Pharmacokinetic data | |
Bioavailability | 99% oral |
Protein binding | yes |
Metabolism | Hepatic |
Biological half-life | ? |
Excretion | Renal |
Identifiers | |
CAS Number | 521-11-9 |
ATC code | None |
PubChem | CID 10633 |
ChemSpider | 10187 |
UNII | S712YZ168E |
KEGG | D01533 |
ChEMBL | CHEMBL261514 |
Synonyms | (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-one |
Chemical data | |
Formula | C20H32O2 |
Molar mass | 304.467 g/mol |
| |
| |
(what is this?) (verify) |
Mestanolone is the 17α-methylated version of dihydrotestosterone (DHT).[1] The systematic name of mestanolone is: 17β-hydroxy-17α-methylandrost-3-one.[2] It is an orally bioavailable androgenic steroid that is highly androgenic while only slightly anabolic. It is incapable of aromatization and is not an agonist of the progesterone receptor.
Dosage Information
Dosages range from 10 mg to 30 mg a day for males. Women should avoid Mestanolone for it is very androgenic. Long term use, more than 12 weeks should be avoided do to hepatoxicity. Since Mestanolone is unable to convert to estrogen, it is very useful during cutting phases or when one wishes to avoid excess weight gain.
References
- ↑ CTD (2007). "Chemicals: mestanolone". CTD - Comparative Toxicogenomics Database. Retrieved September 3, 2007.
- ↑ Biology Online.org (2007). "mestanolone". Biology Online.org. Retrieved September 3, 2007.
|
This article is issued from Wikipedia - version of the Thursday, January 28, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.